期刊文献+

马兜铃酸Ⅰ致人上尿路上皮细胞MMP9、VEGF、E-cadherin、ERK的活性变化

Aristolochic Acid Ⅰ Induced Abnormalities in Expressions of MMP9,VEGF,E- cadherin and ERK 1 /2 Activation in Human Urothelium SV-HUC-1 Cells and in Upper Urothelial Ccarcinomas
下载PDF
导出
摘要 目的探讨马兜铃酸Ⅰ(aristolochic acidⅠ,AAⅠ)诱导的可能癌变机制。分析AAⅠ能否诱导人尿路上皮细胞(SV-HUC-1)MMP9、VEGF、E-cadherin的表达。方法 SV-HUC-1细胞暴露于低浓度的AAⅠ(2.5、5.0、10μg/ml)48h,用蛋白免疫印迹(Western blot)法和荧光定量PCR分析MMP9、VEGF、E-cadherin的表达。此外用Western blot法比较马兜铃酸相关上尿路肿瘤(upper urothelial carcinomas associated with aristolochic acid nephropathy,AA-UUC)和非马兜铃酸相关上尿路肿瘤(nonAA-UUC)MMP9、VEGF、E-cadherin、PERK1/2蛋白表达变化。结果随着AAⅠ浓度的增加,MMP9、VEGF逐渐表达增加,而E-cadherin表达下降。然而,当SV-HUC-1细胞预先用ERK1/2信号通路抑制剂(U0126)作用1h,MMP9、VEGF蛋白的表达被抑制,而E-cadherin蛋白的表达恢复。和non-AA-UUC相比,AA-UUC的MMP9、VEGF、PERK1/2呈高表达,而E-cadherin呈低表达。结论低密度的AAⅠ可能通过激活SV-HUC-1细胞的ERK1/2信号通路使MMP9、VEGF、E-cadherin表达失调。马兜铃酸(AA)可能是上尿路肿瘤发生的原因之一。 Objective To investigate the mechanism of Aristolochic acid Ⅰ (AA Ⅰ)-induced carcinogenesis and whether AA Ⅰ induced the expressions of MMP9,VEGF,E-cadherin in human uroepithelial cells(SV-HUC-1).Methods After SV-HUC-1 cells were treated with low concentration of AA Ⅰ (2.5,5.0,10.0μg/ml) for 48h,Western blotting and qRT-PCR were used to detect the expression of MMP9,VEGF and E-cadherin.What's more,we aslo used Western blotting to compare the expression of MMP9,VEGF,E-cadherin,PERK1/2 between upper urothelial carcinomas associated with Aristolochic acid Nephropathy(AA-UUC) and common upper urothelial carcinomas(non-AA-UUC).Results When the concentration of AA Ⅰ increased,the expression of MMP9,VEGF increased but the E-cadherin decreased.However,when cells were pretreated with ERK1/2 signaling pathway inhibitors U0126 for 1h prior to exposure to AA Ⅰ,the effect of AA Ⅰ on expression of MMP9,VEGF levels was suppresssed but assisted the expression levels of E-cadherin.Morover,compared to non-AA-UUC,the expression of MMP9,VEGF,PERK1/2 on AA-UUC showd high but the expression of E-cadherin was low.Conclusion These findings suggest that low concentration of AA Ⅰ might induce MMP9,VEGF,E-cadherin dysregulation through ERK1/2 activation in SV-HUC-1 cells.AA might be associated with upper urinary tract urothelial carcinomas(UUC).
出处 《医学研究杂志》 2014年第7期125-130,共6页 Journal of Medical Research
  • 相关文献

参考文献21

  • 1Martinek V,Kubickova B,Arlt VM,et al.Comparison of activation of aristolochic acid Ⅰ and Ⅱ with NADPH:quinone oxidoreductase,sulphotransferases and N-acetyltranferases[J] .Neuro Endocrinol Lett,2011,32 Suppl 1:57-70.
  • 2Shibutani S,Dong H,Suzuki N,et al.Selective toxicity of aristolochic acids Ⅰ and Ⅱ[J] .Drug Metab Dispos,2007,35(7):1217-1222.
  • 3Jelakovic B,Karanovic S,Vukovic-Lela I,et al.Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid[J] .KidneyInt,2012,81(6):559-567.
  • 4Hranjec T,Kovac A,Kos J,et al.Endemic nephropathy:the case for chronic poisoning by aristolochia[J] .Croat Med J,2005,46(1):116-125.
  • 5Gunay LM,Akdogan B,Koni A,et al.Upper urinary tract transitional cell carcinoma:is there a best[J] .Clin Genitourin Cancer,2013,11(1):39-44.
  • 6Hsieh SC,Lin IH,Tseng WL,et al.Prescription profile of potentially aristolochic acid containing Chinese herbal products:an analysis of National Health Insurance data in Taiwan between 1997 and 2003[J] .Chin Med,2008,3:13.
  • 7Wu M J,Lian JD,Yang CR,et al.High cumulative incidence of urinary tract transitional cell carcinoma after kidney transplantation in Taiwan[J] .Am J Kidney Dis,2004,43(6):1091-1097.
  • 8de Freitas Silva BS,Yamamoto-Silva FP,Pontes HA,et al.E-cadherin downregulation and Twist overexpression since early stages of oral carcinogenesis[J] .J Oral Pathol Med,2014,43 (2):125-131.
  • 9Kim DW,Walker RL,Meltzer PS,et al.Complex temporal changes in TGFbeta oncogenic signaling drive thyroid carcinogenesis in a mouse model[J] .Carcinogenesis,2013,34(10):2389-2400.
  • 10Wang YH,Yeh SD,Wu MM,et al.Comparing the joint effect of arsenic exposure,cigarette smoking and risk genotypes of vascular endothelial growth factor on upper urinary tract urothelial carcinoma and bladder cancer[J] .J Hazard Mater,2013,262:1139-1146.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部